Inside the Perimenopause Industrial Complex

Perimenopause diagnostic tools and hormone replacement therapy products have grown into a multi-billion-dollar market segment targeting women in their 40s and 50s. The sector includes technology companies offering symptom-tracking apps, telemedicine platforms, compounding pharmacies, and supplement manufacturers. Medical organizations including the American College of Obstetricians and Gynecologists and the North American Menopause Society have issued updated clinical guidelines on hormone therapy in recent years. Several venture capital firms have funded startups in this space, and some marketing campaigns have specifically targeted millennial-aged women approaching or entering perimenopause.

Next story